[Report] Life sciences in 2026: optimism, pressure & strategic shifts
The global life sciences sector is entering 2026 in a period of significant change. Leaders are balancing growth ambitions with ongoing uncertainty around funding, regulation, competition, and geopolitics.
To better understand how organizations are planning for the year ahead, Nature Research Intelligence (NRI), part of Nature Partnerships, has launched the 2026 Life Sciences Market Sentiment Report — a global, survey‑based analysis of priorities, risks, and opportunities across the life sciences industry. Launched in April, this second annual edition provides an evidence‑based snapshot of how life sciences leaders are thinking about growth, innovation, and resilience in the year ahead.
Download the full report here >>
Turning market data into insight
The 2026 Life Sciences Market Sentiment Report explores how organizations are navigating uncertainty and where leadership teams see the most significant risks and opportunities as they plan for 2026 and beyond. By grounding its findings in direct input from decision‑makers, the report offers a practical view of market sentiment across pharma, biotech, medtech, and adjacent life sciences sectors.
Key life sciences trends shaping 2026
The findings point to a picture of cautious optimism. While many leaders expect growth, they remain acutely aware of ongoing pressures around funding, regulation, competition, and geopolitics. Strategic priorities continue to center on:
- Innovation and new product development
- Regional expansion and market diversification
- Operational efficiency and resilience
Looking ahead, automation and artificial intelligence are widely seen as having the greatest potential impact over the next three to five years — influencing R&D productivity, decision‑making, and organizational agility. Together, these insights highlight a sector balancing long‑term confidence with near‑term realism.
Why market sentiment matters for life sciences leaders
The report offers an evidence‑based view of market sentiment, helping organizations understand how peers across pharma, biotech, medtech, and related sectors are approaching the future—a critical context for strategic planning, investment decisions, and partnership development.
Explore the full report
For senior leaders in strategy, R&D, and commercial roles, the report provides a practical view of how organizations are navigating uncertainty and planning for growth in 2026.
Access the 2026 Life Sciences Market Sentiment Report >>
